Shanghai Aidu Biotechnology is a premier, research-driven manufacturer specializing in nutraceutical ingredients. With over a decade of expertise and a state-of-the-art R&D center equipped with advanced LC-MS/GC-MS technology, we provide premium ingredients for the global pharmaceutical, nutraceutical, and cosmetic industries. As a market leader in anti-aging & longevity ingredients, Aidu Biotech ensures superior quality and seamless supply chain reliability through our self-owned production facilities and strategic US-based warehousing.Click Here to Learn More.
Strategic Footprint
Integrated Global Supply Chain: From Scientific Innovation to Industrial Scale.
Aidu Biotech has established a powerful, synergized network that seamlessly bridges advanced research with large-scale industrialization.
Through this integrated "Shanghai-Sichuan-USA" architecture, we have mastered the entire lifecycle—from R&D and raw material procurement to advanced manufacturing and final delivery. This end-to-end capability allows us to significantly shorten the innovation-to-market cycle, offering our clients unparalleled supply chain resilience and competitive advantage.
Innovation Hub in Shanghai: Our global headquarters, strategically located in the heart of Shanghai’s CBD, serves as the brain for strategic decision-making, global sales, and front-end innovation.
Industrial Anchor in Sichuan: We operate a massive 130,000-square-meter state-of-the-art production facility in Sichuan, China. This hub is powered by a dedicated team of elite research technicians and engineers, ensuring that every batch meets the highest standards of purity and consistency.
Localized Supply in Los Angeles: To ensure seamless global delivery, we maintain a dedicated local warehouse in Los Angeles, USA, providing our North American partners with immediate stock availability and significantly reduced lead times.
Shanghai Aidu Biotechnology has completed an overseas shipment of its proprietary ProFisetin®, along with β-NMN and β-NAD+. ProFisetin® is supported by zebrafish model data and third-party testing, ensuring high purity and traceability for the global nutraceutical and sports nutrition industries. The company remains committed to providing stable, science-backed ingredient solutions to its international partners.
Beyond the Gym: Creatine Monohydrate Emerges as a New Growth Pole in Brain Health
The global creatine monohydrate market is projected to skyrocket to USD 659 million by 2031 with a 10.5% CAGR. Driven by a 2024 landmark systematic review in Frontiers in Nutrition, creatine is gaining recognition for its significant benefits in memory and information processing speed. As the "Muscle-Brain Axis" hypothesis gains traction, creatine is transitioning into a foundational health component for students, professionals, and healthy aging.
2026 Liver Health Milestone: Meta-Analysis Confirms DHM’s Metabolic Potential
According to a landmark 2026 meta-analysis in Frontiers in Nutrition, Dihydromyricetin (DHM) significantly improves liver function biomarkers and activates the AMPK pathway. As the market reaches $1.5B, DHM is becoming a cornerstone for metabolic health formulations.
From the Gym to the Office: In 2026, Creatine Is Redefining the Global
Creatine is no longer exclusively for athletes. With the rise of biohacking and longevity awareness, highly stable, bioavailable creatine is becoming a core ingredient in nootropic and anti-aging formulations. This article explores the 11% increase in brain energy reserves and the technical solutions for stable RTDs and gummies provided by Shanghai Aidu Biotechnology.
As the GLP-1 market reshapes the metabolic health landscape, natural alternatives like DHMSober™ (Dihydromyricetin) are gaining traction. Beyond hangover recovery, new research highlights its potential in supporting GLP-1 related pathways and energy metabolism. Discover why brands are integrating this high-purity vine tea extract into weight management and longevity formulations.
